Future of anti‐inflammatory therapy in asthma
- 1 January 1995
- Vol. 50 (s22) , 27-31
- https://doi.org/10.1111/j.1398-9995.1995.tb02732.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Theophylline in the management of asthma: time for reappraisal?European Respiratory Journal, 1994
- IL-12: Initiation Cytokine for Cell-Mediated ImmunityScience, 1993
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- Induction of TH1 and TH2 responses: a key role for the ‘natural’ immune response?Immunology Today, 1992
- ForewordJournal of Allergy and Clinical Immunology, 1991
- Structural Cell-Derived Cytokines in Allergic InflammationInternational Archives of Allergy and Immunology, 1991
- Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectinNature, 1990
- The assessment and treatment of asthma: A conference reportJournal of Allergy and Clinical Immunology, 1990
- The eosinophil as a mediator of damage to respiratory epithelium: A model for bronchial hyperreactivityJournal of Allergy and Clinical Immunology, 1988
- Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthmaJournal of Allergy and Clinical Immunology, 1987